Calbindin-D28k: A marker of recurrence for medulloblastomas

Cancer

Volumn 95, Issue 2, 2002, Pages 410-419

  Pelc, Karine ^a   Vincent, Sylvie ^b   Ruchoux, Marie Magdeleine ^b   Kiss, Robert ^c,d   Pochet, Roland ^c   Sariban, Eric ^a   Decaestecker, Christine ^c,d   Heizmann, Claus W ^e  

^a Hôpital des Enfants   (Belgium)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d FNRS   (Belgium)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Brain medulloblastoma; Ca2+ binding protein; Calbindin D28k; Prognosis; Recurrence

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN; PROTEIN P53; PROTEIN S 100;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION REGULATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0037099689     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10666     Document Type: Article

References (53)

1. Radiation therapy in the management of childhood brain tumors
2. Prognostic factors in medulloblastoma
3. Current therapy and new perspectives in the treatment of medulloblastoma
4. Medulloblastoma
5. The versatility and universality of calcium signalling
6. Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy
7. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma
8. Role of Olf-1 and Pax-6 transcription factors in neurodevelopment
9. Pax in development
10. The roles of engrafted protein
11. Engrailed, Wnt and Pax genes regulate midbrainhindbrain development
12. Deregulated expression of PAX-5 in medulloblastomas
13. Differential expression between PAX-6 and EN proteins in medulloblastoma
14. Expression of the photoreceptor-specific S-antigen in human retinoblastoma
15. Characterization of the astroglial versus the oligodendroglial origin of glioblastornas by means of quantitative morphonuclear variables generated by computer-assisted microscopy
16. The combined determination of proliferative activity and cell density to identify short- as opposed to long-surviving adult patients with supratentorial high-grade astrocytic tumors
17. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters
18. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system
19. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins
20. Human recombinant alpha-parvalbumin and nine mutants with individually inactivated calcium- and magnesium-binding sites: Biochemical and immunological properties
21. Purification and cation binding properties of the recombinant human S100 calcium-binding protein A3, an EF-hand motif protein with high affinity for zinc
22. Expression pattern of S100 calcium-binding proteins in human tumors
23. Immunohistochemical evaluation of the Ca2+-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors
24. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily
25. Correlation of Ecadherin expression with differentiation grade and histological type in breast carcinoma
26. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca2+-binding S100 proteins
27. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin
28. Diagnostic markers in paediatric medulloblastoma: A Paediatric Oncology Group Study
29. Cellular and molecular pathology of medulloblastoma
30. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
31. C-MYC expression in medulloblastoma and its prognostic value
32. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma
33. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas
34. Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma
35. The S100 family of EF-hand calcium-binding proteins: Functions and pathology
36. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
37. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours
38. Prognostic implications of calbindin-D28k expression in lung cancer: Analysis of 452 cases
39. Activation of programmed cell death by calcium: Protection against cell death by the calcium binding protein, calbindin-D28k
40. Stable expression of the calbindin-D28k complementary DNA interferes with the apoptotic pathway in lymphocytes
41. Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity
42. Calbindin-D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function
43. Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells
44. Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide
45. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med
46. Comparison of calbindin-D28k and S-100 protein B in neuroblastoma determined by enzyme immunoassay
47. Differential expression of calretinin, calbindin-D28k and parvalbumin in the developing human cerebellum
48. Oncomodulin in normal and transformed cells
49. Human alpha and beta parvalbumins. Structure and tissue-specific expression
50. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex
51. Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: Phylogenetic and developmental patterns
52. Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases